Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience

被引:121
作者
Hinerman, RW
Mendenhall, WM
Morris, CG
Amdur, RJ
Werning, JW
Villaret, DB
机构
[1] Univ Florida, Shands Canc Ctr, Dept Radiat Oncol, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Otolaryngol, Gainesville, FL 32610 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2004年 / 26卷 / 11期
关键词
carcinoma; squamous cell; mouth; radiotherapy; mouth neoplasms; postoperative care;
D O I
10.1002/hed.20091
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to analyze factors influencing outcome in patients who received postoperative irradiation for advanced squamous cell carcinoma of the oral cavity. Methods. Between October 1964 and November 2000, 226 patients with 230 previously untreated primary invasive squamous cell carcinomas of the oral cavity were treated postoperatively with continuous-course external beam irradiation. All patients had a minimum follow-up of 2 years (analysis, November 2002). No patient was lost to follow-up. Results. The 5-year actuarial rates of locoregional control by pathologic American Joint Committee on Cancer stage were. stage I, 100% stage II, 84%; stage III, 78%; and stage IV, 66%. Recurrence of cancer above the clavicles developed in 55 patients (24%). In multivarlate analysis of locoregional control, positive margins, vascular invasion, perineural invasion, extracapsular extension, and T classification remained significant, Conclusions. This article provides additional data defining relatively favorable and unfavorable groups of patients in the postoperative setting. Dose recommendations are re-examined and selectively increased for high-risk patients. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:984 / 994
页数:11
相关论文
共 60 条
[1]  
*AM JOINT COMM CAN, 1998, AJCC CANC STAG HDB
[2]   POSTOPERATIVE IRRADIATION FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - AN ANALYSIS OF TREATMENT RESULTS AND COMPLICATIONS [J].
AMDUR, RJ ;
PARSONS, JT ;
MENDENHALL, WM ;
MILLION, RR ;
STRINGER, SP ;
CASSISI, NJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (01) :25-36
[3]  
AMPIL RL, 1998, LARYNGOSCOPE, V98, P888
[4]   Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer [J].
Ang, KK ;
Trotti, A ;
Brown, BW ;
Garden, AS ;
Foote, RL ;
Morrison, WH ;
Geara, FB ;
Klotch, DW ;
Goepfert, H ;
Peters, LJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :571-578
[5]  
[Anonymous], SAS ONL VERS 8
[6]   The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: Secondary analysis of RTOG 85-03 [J].
Aref, A ;
Berkey, BA ;
Schwade, JG ;
Ensley, J ;
Schuller, DE ;
Haselow, RE ;
Ervin, TJ ;
Laramore, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (02) :389-394
[7]  
ARRIAGADA R, 1983, CANCER, V51, P1819, DOI 10.1002/1097-0142(19830515)51:10<1819::AID-CNCR2820511011>3.0.CO
[8]  
2-G
[9]   Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial [J].
Bachaud, JM ;
CohenJonathan, E ;
Alzieu, C ;
David, JM ;
Serrano, E ;
DalySchveitzer, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05) :999-1004
[10]  
BARTELINK H, 1983, CANCER-AM CANCER SOC, V52, P1008, DOI 10.1002/1097-0142(19830915)52:6<1008::AID-CNCR2820520613>3.0.CO